Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes Research Letter

   

Authors:	Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Horwitz, S. M.; Johnson, W.; Moskowitz, A. J.; Myskowski, P.; Pulitzer, M.; Geller, S.
Title:	Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes
Keywords:	adult; human tissue; treatment outcome; middle aged; major clinical study; overall survival; follow up; letter; progression free survival; cohort analysis; retrospective study; cutaneous t cell lymphoma; lymphoma; therapy effect; drug therapy; mycosis fungoides; hispanic; sezary syndrome; human; male; female; dupilumab
Journal Title:	Journal of the European Academy of Dermatology and Venereology
Volume:	39
Issue:	2
ISSN:	0926-9959
Publisher:	Wiley Blackwell
Date Published:	2025-02-01
Start Page:	e114
End Page:	e117
Language:	English
DOI:	10.1111/jdv.20141
PUBMED:	38818876
PROVIDER:	scopus
PMCID:	PMC11607143
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195109168&doi=10.1111%2fjdv.20141&partnerID=40&md5=7571f07b87a51f4d338c2d4957512b86
Notes:	Letter -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Robert Stuver -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/223002